We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Is Household Segment Strength Enough to Sustain Clorox's Growth?
Read MoreHide Full Article
Key Takeaways
Clorox's Cleaning business is gaining share as PURE and Scentiva launches beat expectations.
Litter packaging, pricing and shelf-placement changes are slowing recovery despite distribution gains.
ERP completion, shelf resets and pricing actions are expected to improve execution across the portfolio.
The Clorox Company's (CLX - Free Report) Household segment remains its biggest source of stability, but recent commentary suggests that strength in one business alone may not be enough to drive broader growth. While the segment continues to benefit from solid demand in cleaning products and successful innovation, weakness in a few other categories is weighing on the company's overall momentum.
Management highlighted that the Cleaning business is the portfolio's standout performer. Product launches, including the Clorox PURE allergen platform and additions to the Scentiva lineup, are gaining shelf space, generating strong early consumer response and outperforming internal expectations. Despite an intensely promotional environment, the company has said that it continues to gain market share in cleaning, reinforcing the strength of its flagship brands.
However, the positive momentum in Household is being offset elsewhere. Fresh Step cat litter remains in the middle of a multi-year transformation, with new packaging, product claims and pricing architecture creating temporary disruption. Although distribution gains have met expectations, shelf placement issues and the complexity of converting shoppers to new products have slowed the recovery. Management also acknowledged that Food categories remain under pressure from elevated promotions and weaker-than-expected category demand.
Clorox believes execution rather than demand is the key variable. With the ERP rollout completed, management expects better service levels, stronger on-shelf execution and faster commercialization of innovation. Retail distribution points increased more than 5% in the third quarter of fiscal 2026, while additional shelf resets are expected through the fourth quarter. The company is also expanding revenue growth management initiatives, targeted pricing actions and brand investments to strengthen value perception.
The Household segment provides an important foundation, but Clorox's ability to sustain long-term growth will ultimately depend on whether improvements in Litter, Food and other businesses can match the momentum already visible in Cleaning.
CLX’s Price Performance, Valuation & Estimates
Shares of the Zacks Rank #4 (Sell) company have lost 7.6% in the past three months against the industry’s growth of 5%.
Image Source: Zacks Investment Research
From a valuation standpoint, CLX trades at a forward price-to-earnings ratio of 15.66X compared with the industry’s average of 17.59X.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for CLX’s fiscal 2026 earnings implies a year-over-year decline of 27.3%, while that of fiscal 2027 shows growth of 11.5%. The company’s EPS estimate for fiscal 2026 has been unchanged in the past 30 days.
Image Source: Zacks Investment Research
Stocks to Consider in the Consumer Staples Space
United Natural Foods (UNFI - Free Report) is the leading distributor of natural, organic and specialty food and non-food products in the United States and Canada. The company currently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for United Natural Foods’ current financial-year EPS indicates growth of a whopping 254.9% from the prior-year reported level. UNFI delivered a trailing four-quarter earnings surprise of 29.9%, on average.
Church & Dwight Co. Inc. (CHD - Free Report) develops, manufactures and markets a broad range of household, personal care and specialty products. The company currently has a Zacks Rank of 2 (Buy).
The Zacks Consensus Estimate for CHD’s 2026 EPS indicates growth of 6.2% from the previous year’s reported figure. Church & Dwight delivered a trailing four-quarter average earnings surprise of 6.5%.
Krispy Kreme (DNUT - Free Report) operates as a branded retailer and wholesaler of doughnuts, coffee and other complementary beverages and treats and packaged sweets. The company currently carries a Zacks Rank of 2.
The Zacks Consensus Estimate for Krispy Kreme’s current financial-year EPS indicates growth of 30% from the year-ago reported number. DNUT delivered a trailing four-quarter negative earnings surprise of 6.3%, on average.
View the Zacks #1 Rank List
Image: Bigstock
Is Household Segment Strength Enough to Sustain Clorox's Growth?
Key Takeaways
The Clorox Company's (CLX - Free Report) Household segment remains its biggest source of stability, but recent commentary suggests that strength in one business alone may not be enough to drive broader growth. While the segment continues to benefit from solid demand in cleaning products and successful innovation, weakness in a few other categories is weighing on the company's overall momentum.
Management highlighted that the Cleaning business is the portfolio's standout performer. Product launches, including the Clorox PURE allergen platform and additions to the Scentiva lineup, are gaining shelf space, generating strong early consumer response and outperforming internal expectations. Despite an intensely promotional environment, the company has said that it continues to gain market share in cleaning, reinforcing the strength of its flagship brands.
However, the positive momentum in Household is being offset elsewhere. Fresh Step cat litter remains in the middle of a multi-year transformation, with new packaging, product claims and pricing architecture creating temporary disruption. Although distribution gains have met expectations, shelf placement issues and the complexity of converting shoppers to new products have slowed the recovery. Management also acknowledged that Food categories remain under pressure from elevated promotions and weaker-than-expected category demand.
Clorox believes execution rather than demand is the key variable. With the ERP rollout completed, management expects better service levels, stronger on-shelf execution and faster commercialization of innovation. Retail distribution points increased more than 5% in the third quarter of fiscal 2026, while additional shelf resets are expected through the fourth quarter. The company is also expanding revenue growth management initiatives, targeted pricing actions and brand investments to strengthen value perception.
The Household segment provides an important foundation, but Clorox's ability to sustain long-term growth will ultimately depend on whether improvements in Litter, Food and other businesses can match the momentum already visible in Cleaning.
CLX’s Price Performance, Valuation & Estimates
Shares of the Zacks Rank #4 (Sell) company have lost 7.6% in the past three months against the industry’s growth of 5%.
Image Source: Zacks Investment Research
From a valuation standpoint, CLX trades at a forward price-to-earnings ratio of 15.66X compared with the industry’s average of 17.59X.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for CLX’s fiscal 2026 earnings implies a year-over-year decline of 27.3%, while that of fiscal 2027 shows growth of 11.5%. The company’s EPS estimate for fiscal 2026 has been unchanged in the past 30 days.
Image Source: Zacks Investment Research
Stocks to Consider in the Consumer Staples Space
United Natural Foods (UNFI - Free Report) is the leading distributor of natural, organic and specialty food and non-food products in the United States and Canada. The company currently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for United Natural Foods’ current financial-year EPS indicates growth of a whopping 254.9% from the prior-year reported level. UNFI delivered a trailing four-quarter earnings surprise of 29.9%, on average.
Church & Dwight Co. Inc. (CHD - Free Report) develops, manufactures and markets a broad range of household, personal care and specialty products. The company currently has a Zacks Rank of 2 (Buy).
The Zacks Consensus Estimate for CHD’s 2026 EPS indicates growth of 6.2% from the previous year’s reported figure. Church & Dwight delivered a trailing four-quarter average earnings surprise of 6.5%.
Krispy Kreme (DNUT - Free Report) operates as a branded retailer and wholesaler of doughnuts, coffee and other complementary beverages and treats and packaged sweets. The company currently carries a Zacks Rank of 2.
The Zacks Consensus Estimate for Krispy Kreme’s current financial-year EPS indicates growth of 30% from the year-ago reported number. DNUT delivered a trailing four-quarter negative earnings surprise of 6.3%, on average.